Most importantly, the lymphocytes of stroke patients and healthy donors were responsive to the CLA treatment: Lymphocytes of stroke patients showed a significantly reduced production of pro-inflammatory cytokines IFN-γ (2775.0 vs. 1915.0 pg/mL, p adj. Here, IFNG is linked to stroke disorder.